Fort Lee, New Jersey, USA, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Herborium® Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company providing unique, all botanical medicines (Botanical Therapeutics®), announced today that its Black Friday and Cyber Monday sales results grew 80% over the same sales events in 2013.
The two 24 hour sales events, known as Black Friday and Cyber Monday, drew unprecedented sales from the USA, Canada and Europe, not only exceeded 2013 sales but maintained the company's healthy margin.
The recent sales results continue to surpass Herborium's 2013 performance confirming expectations for 2014 yearly results. Total Sales for the three quarters of 2014 are 31% higher than the total sales for the year ending 2013, third quarter 2014 gross profit margin increased 80% over the same period during 2013.
"The Company growth in the USA and abroad continues. Herborium will be announcing new sales initiatives commencing in 2014. We look forward to a very successful end of 2014 and to the future growth and profitability of our novel, all natural medicines - Botanical Therapeutics®". Commented Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium Group.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
CONTACT: Contact Information: Herborium Group, Inc. Email: InvestorsRelations@Herborium.com
Source:Herborium Group, Inc.